[HTML][HTML] Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1
Background Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
[HTML][HTML] Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1
X Liu, R Tonello, Y Ling, YJ Gao… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1
X Liu, R Tonello, Y Ling, YJ Gao, T Berta - Journal of Neuroinflammation, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment of cancer …
Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment of cancer …
[HTML][HTML] Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1
X Liu, R Tonello, Y Ling, YJ Gao… - Journal of …, 2019 - jneuroinflammation.biomedcentral …
Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment of cancer.
However, patients receiving paclitaxel often develop an acute pain syndrome for which there …
However, patients receiving paclitaxel often develop an acute pain syndrome for which there …
Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1.
X Liu, R Tonello, Y Ling, YJ Gao… - Journal of …, 2019 - europepmc.org
BACKGROUND: Paclitaxel is a widely used and potent chemotherapeutic agent for the
treatment of cancer. However, patients receiving paclitaxel often develop an acute pain …
treatment of cancer. However, patients receiving paclitaxel often develop an acute pain …
Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1
X Liu, R Tonello, Y Ling, YJ Gao… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-[alpha] and stromal-derived cell factor 1
X Liu, R Tonello, Y Ling, YJ Gao, T Berta - Journal of …, 2019 - go.gale.com
Background Paclitaxel is a widely used and potent chemotherapeutic agent for the treatment
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
of cancer. However, patients receiving paclitaxel often develop an acute pain syndrome for …
Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor 1.
X Liu, R Tonello, Y Ling, YJ Gao… - Journal of …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> Paclitaxel is a widely used and potent
chemotherapeutic agent for the treatment of cancer. However, patients receiving paclitaxel …
chemotherapeutic agent for the treatment of cancer. However, patients receiving paclitaxel …
[PDF][PDF] Paclitaxel-activated astrocytes produce mechanical allodynia in mice by releasing tumor necrosis factor-α and stromal-derived cell factor
X Liu, R Tonello, Y Ling, YJ Gao, T Berta - 2019 - jneuroinflammation.biomedcentral …
Background: Paclitaxel is a widely used and potent chemotherapeutic agent for the
treatment of cancer. However, patients receiving paclitaxel often develop an acute pain …
treatment of cancer. However, patients receiving paclitaxel often develop an acute pain …